An important strategic aim of NCT Heidelberg is the development of novel concepts for the systematic translation of molecular information into clinical action. The newly established NCT PMO (Precision Medicine in Oncology) Program provides a direct path from latest-generation molecular diagnostics within NCT MASTER to prospective, controlled clinical trials that will assess the efficacy of biology-guided cancer therapies and give patients access to targeted drugs that are otherwise not or only rarely available. ? Overview of available trials in Heidelberg.
Swift translation of innovative high-throughput diagnostics into clinical practice
The NCT Program for Ethics and Patient-oriented care (NCT-EPOC) currently aligns the informed consent process with patients’ and providers’ needs and periodically updates a Code of Conduct for handling genetic information. It is closely linked to the interdisciplinary EURAT (Ethical and Legal Aspects of Whole Genome Sequencing) project. EURAT addresses normative questions and aims to develop an ethically and legally informed practice for genomic research in Heidelberg. To this end, EURAT has released guidelines on practical aspects of sequencing the human genome in a medical context.